Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAssura Regulatory News (AGR)

Share Price Information for Assura (AGR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 42.72
Bid: 42.66
Ask: 42.78
Change: 0.12 (0.28%)
Spread: 0.12 (0.281%)
Open: 42.26
High: 42.94
Low: 42.26
Prev. Close: 42.60
AGR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Scrip Calculation Price

14 Sep 2023 09:20

RNS Number : 4606M
Assura PLC
14 September 2023
 

 

14 September 2023

 

Assura plc

 

Scrip Calculation Price

Assura plc ("the Company") announces, in accordance with the terms and conditions of the Company's Scrip Dividend Scheme ("the Scheme"), that the Scrip Calculation Price in respect of the quarterly interim dividend proposed to be paid on 11 October 2023, is 44.73 pence. This is the average closing mid-market price of an ordinary share in the Company for the five dealing days commencing with, and including, the ex-dividend date of 7 September 2023.

If you wish to receive this quarterly interim dividend in cash, you do not need to take any action.

 

If you wish to participate in the Scheme and receive New Shares instead of your cash dividend, you should complete a Mandate, as follows:

 

· If you hold your Ordinary Shares in certificated form, and if you have not already done so, you should complete the Mandate Form (which is available to download from Assura's website www.assuraplc.com) in accordance with the instructions printed thereon and return it to Link Group at 10th Floor, Central Square, 29 Wellington Street, Leeds, LS1 4DL by no later than 4.30 p.m. (London time) on 28 September 2023. The Mandate Form will remain in force for any future dividends in respect of which a Scrip Dividend Alternative is offered, until such time as the Mandate Form is cancelled.

 

· If you hold your Ordinary Shares in uncertificated form via the CREST System, you can only elect to receive dividends in the form of New Shares by submitting a CREST Dividend Election Input Message via the CREST System. Evergreen elections will not be permitted. This means that if you wish to receive New Shares instead of cash as a matter of routine whenever a Scrip Dividend Alternative is offered, you must complete and submit a CREST Dividend Election Input Message on each occasion, otherwise you will receive the relevant dividend in cash.

 

If you have any questions about the Scheme or how it operates, you can contact our Registrar, Link Group, at the address above or by telephone on 0371 664 0321. Lines are open between 9.00am and 5.30pm Monday to Friday, excluding public holidays.

 

Based upon the above Scrip Calculation Price, if all eligible Shareholders were to elect to take up their full entitlement to New Shares in respect of this quarterly interim dividend, approximately 54,363,162 New Shares would be issued. This would represent approximately 1.8 per cent. of the Company's issued share capital as at today's date. The total cash cost of this quarterly interim dividend if no Shareholders were to elect to take up their entitlement (and therefore no New Shares were to be issued) would be approximately £24.3 million.

 

Words and expressions defined in the circular dated 9 December 2015 in relation to the Scheme bear the same meanings in this announcement.

 

This interim dividend will be paid as 100% Property Income Distribution ("PID"). Forms to register for gross PIDs are available on the Company's website. Please click here for PID Forms.

 

- Ends -

 

 

 

For more information, please contact:

Assura plc David Purcell, Investor Relations Director

Tel: 0161 515 2043 Email: Investor@assura.co.uk

 

FGS Global

Gordon Simpson

 

Tel: 0207 251 3801 Email: Assura@fgsglobal.com

 

 

 Notes to Editors

Assura plc is a national healthcare premises specialist and UK REIT based in Warrington, UK - caring for more than 600 primary healthcare buildings, from which over six million patients are served.

 

A constituent of the FTSE 250 and the EPRA* indices, as at 31 March 2023, Assura's portfolio was valued at £2.7 billion.

 

At Assura, we BUILD for health. Assura builds better spaces for people and places, invests in skills and inspires new ways of working, and unlocks the power of design and innovation to deliver lasting impact for communities - aiming for six million people to have benefitted from improvements to and through its healthcare buildings by 2026. 

 

Assura is leading for a sustainable future, targeting net zero carbon across its portfolio by 2040.

 

Further information is available at www.assuraplc.com

 

*EPRA is a registered trademark of the European Public Real Estate Association.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVSFISALEDSEFU
Date   Source Headline
7th Dec 202110:55 amRNSDirector/PDMR Shareholding
2nd Dec 20218:57 amRNSNotice of Dividend
30th Nov 20217:00 amRNSTotal Voting Rights
29th Nov 20217:00 amRNSCapital Markets Webinar
18th Nov 20219:42 amRNSHolding(s) in Company
16th Nov 20215:22 pmRNSHolding(s) in Company
15th Nov 20219:52 amRNSDirector/PDMR Shareholding
11th Nov 20214:32 pmRNSResult of Placing
11th Nov 20217:01 amRNSPrimaryBid offer
11th Nov 20217:00 amRNSProposed equity placing of new ordinary shares
11th Nov 20217:00 amRNSInterim Results 2021
9th Nov 202112:07 pmRNSDirector/PDMR Shareholding
8th Nov 20214:04 pmRNSHolding(s) in Company
5th Nov 20217:00 amRNSInvestor Presentation
29th Oct 20217:00 amRNSNotice of Interim Results
29th Oct 20217:00 amRNSTotal Voting Rights
27th Oct 20213:51 pmRNSHolding(s) in Company
25th Oct 20217:58 amRNSIssue of Consideration Shares
19th Oct 20214:15 pmRNSDirector/PDMR Shareholding
13th Oct 20212:31 pmRNSAppointment of Joint Corporate Broker
11th Oct 20217:00 amRNSScrip Dividend Declaration
7th Oct 20219:14 amRNSDirector/PDMR Shareholding
5th Oct 20217:00 amRNSTrading Update
4th Oct 20212:58 pmRNSHolding(s) in Company
21st Sep 20217:00 amRNSHolding(s) in Company
20th Sep 20214:44 pmRNSHolding(s) in Company
17th Sep 20219:33 amRNSScrip Calculation Price
16th Sep 20214:27 pmRNSHolding(s) in Company
14th Sep 20214:15 pmRNSHolding(s) in Company
13th Sep 20219:08 amRNSHolding(s) in Company
7th Sep 20219:02 amRNSDirector/PDMR Shareholding
2nd Sep 20217:00 amRNSNotice of Dividend
6th Aug 20219:24 amRNSDirector/PDMR Shareholding
30th Jul 20217:00 amRNSTotal Voting Rights
29th Jul 20217:00 amRNSReduction of RCF
28th Jul 20214:23 pmRNSHolding(s) in Company
26th Jul 20215:30 pmRNSHolding(s) in Company
26th Jul 20218:57 amRNSHolding(s) in Company
20th Jul 20211:56 pmRNSDirector/PDMR Shareholding
15th Jul 20219:56 amRNSExercise of Nil Cost Options under PSP
12th Jul 20211:00 pmRNSScrip Dividend Declaration
8th Jul 202112:20 pmRNSDirector/PDMR Shareholding
8th Jul 202110:08 amRNSDirector/PDMR Shareholding
6th Jul 20212:15 pmRNSResult of AGM
6th Jul 202111:39 amRNSAdditional Listing
6th Jul 20217:00 amRNSTrading Update
28th Jun 20211:02 pmRNSHolding(s) in Company
23rd Jun 20214:01 pmRNSPricing of £300m Sustainability Bond
22nd Jun 20215:05 pmRNSHolding(s) in Company
17th Jun 20219:52 amRNSScrip Calculation Price

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.